Hormesis and public health: can glutathione depletion and mitochondrial dysfunction due to very low-dose chronic exposure to persistent organic pollutants be mitigated
Product quality varies widely among commercial sources operating outside pharmaceutical oversight
The objectives of the study were two-fold: 1) To determine whether MSC, G-CSF, and Dihexa alone or in combination therapy can improve limb functional recovery in a sciatic nerve transection-repair model
Several peptide vaccines have been designed for breast, prostate, colorectal, pancreatic, and melanoma cancers, some of which have passed phase I and II clinical trials with promising results [31, 82, 83]
Health Canada told CBC that "BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols." Academics quoted by CBC called the situation untenable